Tirzepatide — lab test, July 2026
COA QZ7M-GU6M matches Accumark Labs's public record. So this test doesn't rest on our review alone — the lab confirms it too.
QZ7M-GU6MTest results
Not on file for this certificate: endotoxins, sterility and heavy metals. A purity figure says nothing about those.
About this test
Label 10 mg · Lab measured 12.68 mg
127% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 3.2 mg using the measured mass, against 2.5 mg on the label — 27% more.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
| Report number | QZ7M-GU6M |
|---|---|
| Portal lookup | ✓ Lab-verified |
| PDF vs portal | Accumark Labs's portal shows validity only |
| Weight | Counts as one lab test |
Independent HPLC purity analysis of Tirzepatide, performed by Accumark Labs on July 2, 2026. Reported purity: 99.936%. Net content: 12.68 mg against 10 mg labeled (127% of label). Tested content exceeds the labeled amount by 27%. Batch POL-T10-19. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion